Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes

Diabetes Care

Volumn 24, Issue 3, 2001, Pages 549-554

  Ryysy, Leena ^a   Yki Järvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 0035089520     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.3.549     Document Type: Article

References (35)

1. Leukocyteendothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion
2. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules
3. Elevated circulating adhesion molecules in NIDDM-potential mediators in diabetic macroangiopathy
4. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock
5. Soluble forms of E-selectin, ICAM-1 and VCAM- 1 are present in the supematams of cytokine activated cultured endothelial cells
6. Increased levels of soluble adhesion molecules in type 2 (noninsulin dependent) diabetes mellitus are independent of glycaemic control
7. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress
8. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
9. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factoralpha production in NIDDM patients after gliclazide treatment
10. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM: Effect of intensive insulin treatment
11. Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM)
12. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus
13. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation
14. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria
15. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients
16. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulindependent diabetes
17. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first-degree relatives of NIDDM patients and in NIDDM patients
18. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients
19. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: A randomized, controlled trial
20. Minimization: A new method of assessing patients to treatment and control groups
21. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
22. Cellular adhesion molecules and atherogenesis
23. Impaired endothelium-dependent vasodilatation in N1DDM: Relation to LDL size, oxidized LDL and antioxidants
24. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients
25. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion
26. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells
27. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
28. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes
29. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes
30. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factoralpha production in N 1DDM patients after gliclazide treatment
31. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty
32. Elevated soluble E-selectin in cutaneous lupus erythematosus
33. Increased serum levels of soluble vascular celt adhesion molecule 1 and E-selectin in patients with localized scleroderma
34. Soluble E-selectin as a marker of disease activity in pustulosis palmaris et plantaris
35. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: Correlations with clinicopathological features and prognosis